Please assess the completion status of the following clinical trial:

Trial Title: TDCS and Aphasia Therapy in the Acute Phase After Stroke

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with mild-moderate aphasia (Token Test Score between 7 and 40)~* Inclusion in the first few days after stroke (acute phase)~* Age 18 - 85 years~* Being right-handed~* Mothertongue: Dutch~* Able to undergo functional and specific linguistic testing and therapy in the acute phase following stroke~* Imaging (CT or MRI) prior to inclusion (standard of care)~* Signed Informed Consent~Exclusion Criteria:~* History of other diseases of the central nervous system, psychological disorders and (developmental) speech and or language disorders~* Serious non-linguistic, cognitive disorders (as documented in the patients' medical history and inquired in anamneses)~* Prior brain surgery~* Excessive use of alcohol or drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Aphasia therapy and tDCS (Type: ACTIVE_COMPARATOR): None
- Aphasia therapy and sham-tDCS (Type: SHAM_COMPARATOR): None
- Standard of care and sham-tDCS (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).